Trial
NCT01145326
Functional Microarray Augmentation of Skin Treatment With Lidocaine
Phase IIWITHDRAWNREGULATORYConfidence: MEDIUM
Sponsor
University of Oklahoma
Collaborators
—
Condition
Pain Perception
Intervention
4% lidocaine gel application with sham microneedle device
Why stopped
The device is undergoing further study in China, per FDA requirements.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-16